BaroSense, Inc.

With one in three adult Americans struggling with obesity and demand increasing for less invasive or incisionless alternatives to gastric bypass surgery and laparoscopic adjustable gastric banding to

by Anne Staylor With its blockbuster potential, the market for obesity products has been an attractive yet somewhat elusive market for the drug and medical device communities. A significant amount of

Companies with minimally invasive devices for the treatment of obesity hope to fill the therapy gap between dieting and invasive surgery. It's too early to claim victory, but start-ups and scientists

by Anne Staylor With soaring medical costs weighing heavily on the US economy, it is not surprising that obesity has become a target in the health care reform debate. There is an undeniable link betwe